Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s stock price fell 0.6% on Tuesday . The company traded as low as $47.21 and last traded at $47.21. 203 shares traded hands during mid-day trading, a decline of 72% from the average session volume of 717 shares. The stock had previously closed at $47.50.
Hikma Pharmaceuticals Stock Performance
The company’s fifty day moving average price is $49.99 and its two-hundred day moving average price is $50.13.
Hikma Pharmaceuticals Cuts Dividend
The company also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Tuesday, August 20th were issued a $0.62 dividend. The ex-dividend date of this dividend was Monday, August 19th. This represents a yield of 2.98%. Hikma Pharmaceuticals’s dividend payout ratio (DPR) is presently 10.34%.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Read More
- Five stocks we like better than Hikma Pharmaceuticals
- What is Put Option Volume?
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Trading Halts Explained
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- What is a Dividend King?
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
